The global cancer biomarkers market is estimated to be valued at US$ 380.84 Bn in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Swot Analysis
Strength: Cancer biomarkers have the potential to revolutionize cancer diagnosis, prognosis, and management. They allow for more...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian